{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:54:00Z","timestamp":1790906040184,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"DOI":"10.1007\/s00210-026-05961-y","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:06:47Z","timestamp":1790842007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vildagliptin attenuates the development of CCl\u2084-induced liver fibrosis: associations with gut\u2013liver axis modulation and LPS\/notch-related signaling"],"prefix":"10.1007","author":[{"given":"Aya M.","family":"Eid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed O.","family":"El-Gendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Gamal El-Din","family":"Ewees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"5961_CR1","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s00204-011-0663-8","volume":"85","author":"MS Abdel-Bakky","year":"2011","unstructured":"Abdel-Bakky MS, Hammad MA, Walker LA, Ashfaq MK (2011) Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline\/LPS renal injury in mice. Arch Toxicol 85:1245\u20131256. https:\/\/doi.org\/10.1007\/s00204-011-0663-8","journal-title":"Arch Toxicol"},{"key":"5961_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2022.999001","volume":"13","author":"M Afzaal","year":"2022","unstructured":"Afzaal M, Saeed F, Shah YA et al (2022) Human gut microbiota in health and disease: unveiling the relationship. Front Microbiol 13:1\u201314. https:\/\/doi.org\/10.3389\/fmicb.2022.999001","journal-title":"Front Microbiol"},{"key":"5961_CR3","doi-asserted-by":"publisher","unstructured":"Akk\u0131z H, Gieseler RK, Canbay A (2024) Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms25147873","DOI":"10.3390\/ijms25147873"},{"key":"5961_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2021.779119","volume":"12","author":"W Almishri","year":"2022","unstructured":"Almishri W, Swain LA, D\u2019Mello C et al (2022) ADAM metalloproteinase domain 17 regulates cholestasis-associated liver injury and sickness behavior development in mice. Front Immunol 12:1\u201314. https:\/\/doi.org\/10.3389\/fimmu.2021.779119","journal-title":"Front Immunol"},{"key":"5961_CR5","doi-asserted-by":"publisher","unstructured":"Amir A, McDonald D, Navas-Molina JA, Kopylova E, Morton JT, Xu ZZ, Kightley EP, Thompson LR, Hyde ER, Gonzalez A, Knight R (2017) Deblur rapidly resolves single-nucleotide community sequence patterns. mSystems 2(2):e00191\u201316. https:\/\/doi.org\/10.1128\/mSystems.00191-16","DOI":"10.1128\/mSystems.00191-16"},{"key":"5961_CR6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijms251910803","volume":"25","author":"N Bakalenko","year":"2024","unstructured":"Bakalenko N, Kuznetsova E, Malashicheva A (2024) The complex interplay of TGF-\u03b2 and notch signaling in the pathogenesis of fibrosis. Int J Mol Sci 25:23\u201325. https:\/\/doi.org\/10.3390\/ijms251910803","journal-title":"Int J Mol Sci"},{"key":"5961_CR7","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00394-016-1317-7","volume":"57","author":"M Balakumar","year":"2018","unstructured":"Balakumar M, Prabhu D, Sathishkumar C et al (2018) Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL\/6J mice. Eur J Nutr 57:279\u2013295. https:\/\/doi.org\/10.1007\/s00394-016-1317-7","journal-title":"Eur J Nutr"},{"key":"5961_CR8","doi-asserted-by":"publisher","unstructured":"Balogh DB, Wagner LJ, Fekete A (2023) An overview of the cardioprotective effects of novel antidiabetic classes: focus on inflammation, oxidative stress, and fibrosis. Int J Mol Sci 24. https:\/\/doi.org\/10.3390\/ijms24097789","DOI":"10.3390\/ijms24097789"},{"key":"5961_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-018-0470-z","volume":"6","author":"NA Bokulich","year":"2018","unstructured":"Bokulich NA, Kaehler BD, Rideout JR et al (2018) Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2\u2019s q2-feature-classifier plugin. Microbiome 6:1\u201317. https:\/\/doi.org\/10.1186\/s40168-018-0470-z","journal-title":"Microbiome"},{"key":"5961_CR10","first-page":"21","volume":"26","author":"M Brahimi","year":"2009","unstructured":"Brahimi M, Osmani S, Arabi A et al (2009) The estimation of platelet count from a blood smear on the basis of the red cell: platelet ratio. Turk J Haematol 26:21\u201324","journal-title":"Turk J Haematol"},{"key":"5961_CR11","doi-asserted-by":"publisher","unstructured":"Cabibi D, Bronte F, Porcasi R, et al (2015) Comparison of histochemical stainings in evaluation of liver fibrosis and correlation with transient elastography in chronic hepatitis. Anal Cell Pathol 2015. https:\/\/doi.org\/10.1155\/2015\/431750","DOI":"10.1155\/2015\/431750"},{"key":"5961_CR12","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3892\/mmr.2014.2207","volume":"10","author":"X-G Cai","year":"2014","unstructured":"Cai X-G, Xia J-R, Li W-D et al (2014) Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis. Mol Med Rep 10:306\u2013314","journal-title":"Mol Med Rep"},{"key":"5961_CR13","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso JG, Kuczynski J, Stombaugh J et al (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335\u2013336","journal-title":"Nat Methods"},{"key":"5961_CR14","doi-asserted-by":"publisher","first-page":"2180","DOI":"10.1002\/hep.30652","volume":"73","author":"YE Cho","year":"2021","unstructured":"Cho YE, Kim DK, Seo W et al (2021) Fructose promotes leaky gut, endotoxemia, and liver fibrosis through ethanol-inducible cytochrome P450\u20132E1\u2013mediated oxidative and nitrative stress. Hepatology 73:2180\u20132195. https:\/\/doi.org\/10.1002\/hep.30652","journal-title":"Hepatology"},{"key":"5961_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2022.942841","volume":"13","author":"YK Dai","year":"2022","unstructured":"Dai YK, Zhao ZM, Liu C (2022) Treatment of liver fibrosis: a 20-year bibliometric and knowledge-map analysis. Front Pharmacol 13:1\u201318. https:\/\/doi.org\/10.3389\/fphar.2022.942841","journal-title":"Front Pharmacol"},{"key":"5961_CR16","doi-asserted-by":"publisher","first-page":"e1795","DOI":"10.1097\/MD.0000000000001795","volume":"94","author":"H Deng","year":"2015","unstructured":"Deng H, Qi X, Guo X (2015) Diagnostic accuracy of APRI, AAR, FIB-4, FI, king, lok, forns, and fibroindex scores in predicting the presence of esophageal varices in liver cirrhosis. Med (United States) 94:e1795. https:\/\/doi.org\/10.1097\/MD.0000000000001795","journal-title":"Med (United States)"},{"key":"5961_CR17","doi-asserted-by":"publisher","first-page":"W180","DOI":"10.1093\/nar\/gkx295","volume":"45","author":"A Dhariwal","year":"2017","unstructured":"Dhariwal A, Chong J, Habib S et al (2017) MicrobiomeAnalyst: a web-based tool for comprehensive statistical, visual and meta-analysis of microbiome data. Nucleic Acids Res 45:W180\u2013W188. https:\/\/doi.org\/10.1093\/nar\/gkx295","journal-title":"Nucleic Acids Res"},{"key":"5961_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","volume":"19","author":"F Di Vincenzo","year":"2024","unstructured":"Di Vincenzo F, Del Gaudio A, Petito V et al (2024) Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review. Intern Emerg Med 19:275\u2013293. https:\/\/doi.org\/10.1007\/s11739-023-03374-w","journal-title":"Intern Emerg Med"},{"key":"5961_CR19","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","volume":"398","author":"P Gin\u00e8s","year":"2021","unstructured":"Gin\u00e8s P, Krag A, Abraldes JG et al (2021) Liver cirrhosis. Lancet (London, England) 398:1359\u20131376. https:\/\/doi.org\/10.1016\/S0140-6736(21)01374-X","journal-title":"Lancet (London, England)"},{"key":"5961_CR20","doi-asserted-by":"publisher","first-page":"853976","DOI":"10.1155\/2013\/853976","volume":"2013","author":"CCM Gon\u00e7alves","year":"2013","unstructured":"Gon\u00e7alves CCM, Hernandes L, Bersani-Amado CA et al (2013) Use of Propolis Hydroalcoholic extract to treat colitis experimentally induced in rats by 2, 4, 6-Trinitrobenzenesulfonic acid. Evidence-Based Complement Altern Med 2013:853976","journal-title":"Evidence-Based Complement Altern Med"},{"key":"5961_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120695","volume":"304","author":"AS Hendawy","year":"2022","unstructured":"Hendawy AS, El-Lakkany NM, Mantawy EM et al (2022) Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades. Life Sci 304:120695. https:\/\/doi.org\/10.1016\/j.lfs.2022.120695","journal-title":"Life Sci"},{"key":"5961_CR22","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00109-021-02083-1","volume":"99","author":"Y Hu","year":"2021","unstructured":"Hu Y, He J, He L et al (2021) Expression and function of Smad7 in autoimmune and inflammatory diseases. J Mol Med 99:1209\u20131220. https:\/\/doi.org\/10.1007\/s00109-021-02083-1","journal-title":"J Mol Med"},{"key":"5961_CR23","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/s41575-022-00688-6","volume":"20","author":"DQ Huang","year":"2023","unstructured":"Huang DQ, Mathurin P, Cortez-Pinto H, Loomba R (2023a) Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors. Nat Rev Gastroenterol Hepatol 20:37\u201349","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5961_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnut.2023.1089909","volume":"10","author":"X Huang","year":"2023","unstructured":"Huang X, Yang Y, Li X et al (2023b) The gut microbiota: a new perspective for tertiary prevention of hepatobiliary and gallbladder diseases. Front Nutr 10:1\u201313. https:\/\/doi.org\/10.3389\/fnut.2023.1089909","journal-title":"Front Nutr"},{"key":"5961_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","volume":"22","author":"K Ishak","year":"1995","unstructured":"Ishak K, Baptista A, Bianchi L et al (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696\u2013699","journal-title":"J Hepatol"},{"key":"5961_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2020.108573","volume":"89","author":"K Ishida","year":"2021","unstructured":"Ishida K, Kaji K, Sato S et al (2021) Sulforaphane ameliorates ethanol plus carbon tetrachloride-induced liver fibrosis in mice through the Nrf2-mediated antioxidant response and acetaldehyde metabolization with inhibition of the LPS\/TLR4 signaling pathway. J Nutr Biochem 89:108573. https:\/\/doi.org\/10.1016\/j.jnutbio.2020.108573","journal-title":"J Nutr Biochem"},{"key":"5961_CR27","doi-asserted-by":"publisher","unstructured":"Kang J, Postigo-Fernandez J, Kim KJ, et al (2023) Notch-mediated hepatocyte MCP-1 secretion causes liver fibrosis. JCI Insight 8. https:\/\/doi.org\/10.1172\/jci.insight.165369","DOI":"10.1172\/jci.insight.165369"},{"key":"5961_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.115246","volume":"407","author":"R Khalil","year":"2020","unstructured":"Khalil R, Shata A, Abd El-Kader EM et al (2020) Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1\/2, p38\u03b1, and NF-\u03baB signaling. Toxicol Appl Pharmacol 407:115246. https:\/\/doi.org\/10.1016\/j.taap.2020.115246","journal-title":"Toxicol Appl Pharmacol"},{"key":"5961_CR29","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41423-023-00987-1","volume":"20","author":"CH Kim","year":"2023","unstructured":"Kim CH (2023) Complex regulatory effects of gut microbial short-chain fatty acids on immune tolerance and autoimmunity. Cell Mol Immunol 20:341\u2013350. https:\/\/doi.org\/10.1038\/s41423-023-00987-1","journal-title":"Cell Mol Immunol"},{"key":"5961_CR30","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva T, Brenner D (2021) Molecular and cellular mechanisms of liver fibrosis and its regression. Nat Rev Gastroenterol Hepatol 18:151\u2013166","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5961_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","volume":"16","author":"Y-S Lee","year":"2023","unstructured":"Lee Y-S, Seki E (2023) In vivo and in vitro models to study liver fibrosis: mechanisms and limitations. Cell Mol Gastroenterol Hepatol 16:355\u2013367. https:\/\/doi.org\/10.1016\/j.jcmgh.2023.05.010","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"5961_CR32","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.3748\/wjg.v28.i28.3555","volume":"28","author":"YG Li","year":"2022","unstructured":"Li YG, Yu ZJ, Li A, Ren ZG (2022) Gut microbiota alteration and modulation in hepatitis B virus-related fibrosis and complications: molecular mechanisms and therapeutic inventions. World J Gastroenterol 28:3555\u20133572. https:\/\/doi.org\/10.3748\/wjg.v28.i28.3555","journal-title":"World J Gastroenterol"},{"key":"5961_CR33","doi-asserted-by":"publisher","DOI":"10.1017\/erm.2024.38","author":"M Li","year":"2024","unstructured":"Li M, Zheng C, Wang H, Wang S (2024) Exploring the antifibrotic mechanisms of ghrelin: modulating TGF-\u03b2 signaling in organ fibrosis. Expert Rev Mol Med. https:\/\/doi.org\/10.1017\/erm.2024.38","journal-title":"Expert Rev Mol Med"},{"key":"5961_CR34","doi-asserted-by":"publisher","DOI":"10.3402\/mehd.v26.27663","volume":"26","author":"S Mandal","year":"2015","unstructured":"Mandal S, Van Treuren W, White RA et al (2015) Analysis of composition of microbiomes: a novel method for studying microbial composition. Microb Ecol Health Dis 26:27663. https:\/\/doi.org\/10.3402\/mehd.v26.27663","journal-title":"Microb Ecol Health Dis"},{"key":"5961_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2024.102408","volume":"48","author":"SA Mangoura","year":"2024","unstructured":"Mangoura SA, Ahmed MA, Hamad N et al (2024) Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat. Clin Res Hepatol Gastroenterol 48:102408. https:\/\/doi.org\/10.1016\/j.clinre.2024.102408","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"5961_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216502","author":"R Maslennikov","year":"2023","unstructured":"Maslennikov R, Poluektova E, Zolnikova O et al (2023) Gut microbiota and bacterial translocation in the pathogenesis of liver fibrosis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms242216502","journal-title":"Int J Mol Sci"},{"key":"5961_CR37","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12876-023-02958-2","volume":"23","author":"F Nazari-Khanamiri","year":"2023","unstructured":"Nazari-Khanamiri F, Jafari A, Esmaeilzadeh Z, Ghasemnejad-Berenji M (2023) Biochemical and histopathological evidence for beneficial effects of Empagliflozin pretreatment on acetic acid-induced colitis in rats. BMC Gastroenterol 23:332","journal-title":"BMC Gastroenterol"},{"key":"5961_CR38","unstructured":"Parkinson M, Mortimer A, Jones C, Larking S, Swartz A (2013) Bancroft\u2019s theory and practice of histological techniques content strategist: Michael Houston content development specialists, 7th edn. Churchill Livingstone, Elsiver,\u00a0Pbl London"},{"key":"5961_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms21218351","volume":"21","author":"J Plaza-D\u00edaz","year":"2020","unstructured":"Plaza-D\u00edaz J, Sol\u00eds-Urra P, Rodr\u00edguez-Rodr\u00edguez F et al (2020) The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage. Int J Mol Sci 21:1\u201322. https:\/\/doi.org\/10.3390\/ijms21218351","journal-title":"Int J Mol Sci"},{"key":"5961_CR40","doi-asserted-by":"publisher","unstructured":"Prud\u2019homme GJ, Kurt M, Wang Q (2022) Pathobiology of the klotho antiaging protein and therapeutic considerations. Front Aging 3 1\u201324. https:\/\/doi.org\/10.3389\/fragi.2022.931331","DOI":"10.3389\/fragi.2022.931331"},{"key":"5961_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jcjd.2019.05.008","volume":"44","author":"PM Ryan","year":"2020","unstructured":"Ryan PM, Patterson E, Carafa I et al (2020) Metformin and dipeptidyl peptidase-4 inhibitor differentially modulate the intestinal microbiota and plasma metabolome of metabolically dysfunctional mice. Can J Diabetes 44:146-155.e2. https:\/\/doi.org\/10.1016\/j.jcjd.2019.05.008","journal-title":"Can J Diabetes"},{"key":"5961_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata N, Izard J, Waldron L et al (2011) Metagenomic biomarker discovery and explanation. Genome Biol 12:R60. https:\/\/doi.org\/10.1186\/gb-2011-12-6-r60","journal-title":"Genome Biol"},{"key":"5961_CR43","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/0886022X.2020.1729189","volume":"42","author":"IO Sherif","year":"2020","unstructured":"Sherif IO, Alshaalan AA, Al-Shaalan NH (2020) Renoprotective effect of vildagliptin following hepatic ischemia\/reperfusion injury. Ren Fail 42:208\u2013215. https:\/\/doi.org\/10.1080\/0886022X.2020.1729189","journal-title":"Ren Fail"},{"key":"5961_CR44","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.18203\/2320-6012.ijrms20241243","volume":"12","author":"S Shoba","year":"2024","unstructured":"Shoba S, Jeeva T, Lokesh J et al (2024) Potential effect of metformin and vildagliptin against isoniazid induced hepatotoxicity in Wistar albino rats. Int J Res Med Sci 12:1571\u20131577. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20241243","journal-title":"Int J Res Med Sci"},{"key":"5961_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2021.695299","volume":"11","author":"SB Singh","year":"2021","unstructured":"Singh SB, Coffman CN, Carroll-Portillo A et al (2021) Notch signaling pathway is activated by sulfate reducing bacteria. Front Cell Infect Microbiol 11:1\u201315. https:\/\/doi.org\/10.3389\/fcimb.2021.695299","journal-title":"Front Cell Infect Microbiol"},{"key":"5961_CR46","doi-asserted-by":"publisher","unstructured":"Somnay K, Wadgaonkar P, Sridhar N, et al (2024) Liver fibrosis leading to cirrhosis: basic mechanisms and clinical perspectives. Biomedicines 12. https:\/\/doi.org\/10.3390\/biomedicines12102229","DOI":"10.3390\/biomedicines12102229"},{"key":"5961_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12931-017-0660-4","volume":"18","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Tada Y, Gladson S et al (2017) Vildagliptin ameliorates pulmonary fibrosis in lipopolysaccharide-induced lung injury by inhibiting endothelial-to-mesenchymal transition. Respir Res 18:1\u201311. https:\/\/doi.org\/10.1186\/s12931-017-0660-4","journal-title":"Respir Res"},{"key":"5961_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/2047-217X-2-16","author":"Y V\u00e1zquez-Baeza","year":"2013","unstructured":"V\u00e1zquez-Baeza Y, Pirrung M, Gonzalez A, Knight R (2013) EMPeror: a tool for visualizing high-throughput microbial community data. Gigascience. https:\/\/doi.org\/10.1186\/2047-217X-2-16","journal-title":"Gigascience"},{"key":"5961_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcimb.2020.00018","volume":"10","author":"S Wan","year":"2020","unstructured":"Wan S, Nie Y, Zhang Y et al (2020) Gut microbial dysbiosis is associated with profibrotic factors in liver fibrosis mice. Front Cell Infect Microbiol 10:1\u201312. https:\/\/doi.org\/10.3389\/fcimb.2020.00018","journal-title":"Front Cell Infect Microbiol"},{"key":"5961_CR50","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4254\/wjh.v16.i7.973","volume":"16","author":"XL Wang","year":"2024","unstructured":"Wang XL, Yang M, Wang Y (2024) Roles of transforming growth factor-\u03b2 signaling in liver disease. World J Hepatol 16:973\u2013979. https:\/\/doi.org\/10.4254\/wjh.v16.i7.973","journal-title":"World J Hepatol"},{"key":"5961_CR51","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00109-021-02044-8","volume":"99","author":"J Xia","year":"2021","unstructured":"Xia J, Cao W (2021) Epigenetic modifications of Klotho expression in kidney diseases. J Mol Med 99:581\u2013592. https:\/\/doi.org\/10.1007\/s00109-021-02044-8","journal-title":"J Mol Med"},{"key":"5961_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2021.792667","volume":"8","author":"H Xu","year":"2021","unstructured":"Xu H, Wang L (2021) The role of Notch signaling pathway in non-alcoholic fatty liver disease. Front Mol Biosci 8:1\u201312. https:\/\/doi.org\/10.3389\/fmolb.2021.792667","journal-title":"Front Mol Biosci"},{"key":"5961_CR53","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.7150\/thno.106597","volume":"15","author":"M Yan","year":"2025","unstructured":"Yan M, Cui Y, Xiang Q (2025a) Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions. Theranostics 15:1715\u20131740. https:\/\/doi.org\/10.7150\/thno.106597","journal-title":"Theranostics"},{"key":"5961_CR54","doi-asserted-by":"publisher","unstructured":"Yan M, Man S, Sun B, et al (2023) Gut liver brain axis in diseases: the implications for therapeutic interventions. Signal Transduct Target Ther 8. https:\/\/doi.org\/10.1038\/s41392-023-01673-4","DOI":"10.1038\/s41392-023-01673-4"},{"key":"5961_CR55","doi-asserted-by":"publisher","unstructured":"Yan S, Zhao Y, Yang Y, Liu, B, Xu W, Ma Z, Yang Q (2025) Progress of ADAM17 in fibrosis\u2010related diseases. Mediators Inflamm 1:9999723. https:\/\/doi.org\/10.1155\/mi\/9999723","DOI":"10.1155\/mi\/9999723"},{"key":"5961_CR56","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1111\/jcmm.14987","volume":"24","author":"JJ Yang","year":"2020","unstructured":"Yang JJ, Yang Y, Zhang C et al (2020) Epigenetic silencing of LncRNA ANRIL enhances liver fibrosis and HSC activation through activating AMPK pathway. J Cell Mol Med 24:2677\u20132687. https:\/\/doi.org\/10.1111\/jcmm.14987","journal-title":"J Cell Mol Med"},{"key":"5961_CR57","doi-asserted-by":"publisher","unstructured":"Ye L, Huang J, Liang X, et al (2024) Jiawei Taohe Chengqi Decoction attenuates CCl4 induced hepatic fibrosis by inhibiting HSCs activation via TGF-\u03b21\/CUGBP1 and IFN-\u03b3\/Smad7 pathway. Phytomedicine 133. https:\/\/doi.org\/10.1016\/j.phymed.2024.155916","DOI":"10.1016\/j.phymed.2024.155916"},{"key":"5961_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173612","volume":"889","author":"RR Yossef","year":"2020","unstructured":"Yossef RR, Al-Yamany MF, Saad MA, El-Sahar AE (2020) Neuroprotective effects of vildagliptin on drug induced Alzheimer\u2019s disease in rats with metabolic syndrome: role of hippocampal klotho and AKT signaling pathways. Eur J Pharmacol 889:173612. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173612","journal-title":"Eur J Pharmacol"},{"key":"5961_CR59","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.7150\/ijbs.60056","volume":"17","author":"Z Yue","year":"2021","unstructured":"Yue Z, Jiang Z, Ruan B et al (2021) Disruption of myofibroblastic Notch signaling attenuates liver fibrosis by modulating fibrosis progression and regression. Int J Biol Sci 17:2135\u20132146. https:\/\/doi.org\/10.7150\/ijbs.60056","journal-title":"Int J Biol Sci"},{"key":"5961_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0184735","volume":"12","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Xiao X, Li M et al (2017) Vildagliptin increases butyrate-producing bacteria in the gut of diabetic rats. PLoS ONE 12:1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0184735","journal-title":"PLoS ONE"},{"key":"5961_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmolb.2021.766855","volume":"8","author":"J Zhang","year":"2021","unstructured":"Zhang J, Liu Q, He J, Li Y (2021) Novel therapeutic targets in liver fibrosis. Front Mol Biosci 8:1\u201317. https:\/\/doi.org\/10.3389\/fmolb.2021.766855","journal-title":"Front Mol Biosci"},{"key":"5961_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fcell.2024.1450038","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Xu Z, Chen Q, Zhou Z (2024a) Notch signaling regulates pulmonary fibrosis. Front Cell Dev Biol 12:1\u201311. https:\/\/doi.org\/10.3389\/fcell.2024.1450038","journal-title":"Front Cell Dev Biol"},{"key":"5961_CR63","doi-asserted-by":"publisher","unstructured":"Zhang Y, Ren L, Tian Y, et al (2024b) Signaling pathways that activate hepatic stellate cells during liver fibrosis. Front Med 11. https:\/\/doi.org\/10.3389\/fmed.2024.1454980","DOI":"10.3389\/fmed.2024.1454980"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05961-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05961-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:02:29Z","timestamp":1790902949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05961-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":63,"alternative-id":["5961"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05961-y","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"19 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Animal Care and Use Committee (IACUC) guidelines of Beni-Suef University, Egypt (approval number BSU-024\u2013257), adhering to the National Institutes of Health (NIH) standards for the care and use of laboratory animals.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","label":"Declaration of competing interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work, the authors used ChatGPT (OpenAI) to improve the clarity and readability of the manuscript. After using this tool, the authors carefully reviewed, edited, and verified the content to ensure accuracy and originality, and they take full responsibility for the content of the publication.","order":3,"name":"Ethics","label":"Declaration of generative ai and ai-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Clinical trial number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}